Gene · 10049
NIH grants1,554
NIH grants whose papers are about the gene, through NIH's grant-paper links.
141 to 160 of 1,554
Download this page as JSON| Grant | Title | DNAJB6 papers | Newest fiscal year |
|---|---|---|---|
| R01CA193842 | Characterizing the MSI2 network in leukemia | 1 | 2025 |
| R01CA198279 | Shaping DNA Damage Response Networks Via Histone H2A Variants | 1 | 2025 |
| R01CA200900 | Systemic RNA Delivery to Tumors | 1 | 2025 |
| R01CA207513 | Role of KLHL6 inactivation in mature B-cell malignancies | 1 | 2025 |
| R01CA260356 | Anti-tumor potential of temperature-sensitive p53 mutants | 1 | 2025 |
| R01CA269897 | Potentiating a systemic antitumor response by interstitial localized ablative immunotherapy to synergize with immune checkpoint therapy for metastatic pancreatic tumors | 1 | 2025 |
| R01DA008863 | Regulation Of Opioid Receptor Signaling by Endogenous Peptides | 1 | 2025 |
| R01DC008853 | Functional development of hair cells and neurons in the inner ear | 1 | 2025 |
| R01DK105056 | Activating Autophagy to Treat Uromodulin-Associated Genetic Chronic Kidney Disease | 1 | 2025 |
| R01DK131550 | Novel cytoskeletal mechanisms of pathogenic bacteria interactions with intestinal epithelium | 1 | 2025 |
| R01ES030335 | Replication fork dynamics and repair by Rad51 paralogs after DNA alkylation | 1 | 2025 |
| R01ES031796 | RAD51 paralog function in cancer predisposition and genome integrity | 1 | 2025 |
| R01ES031979 | Nickel and toxic topoisomerase I products | 1 | 2025 |
| R01EY023557 | Primary Open Angle African-American Glaucoma Genetics Study Renewal | 1 | 2025 |
| R01GM026017 | Enzymatic Mechanisms of Genetic Recombination | 1 | 2025 |
| R01GM088253 | Template-based replication of the centriole organelle | 1 | 2025 |
| R01GM105672 | The mechanism of ESCRT-mediated surveillance of the nuclear envelope barrier | 1 | 2025 |
| R01GM131641 | Mapping endogenous protein dynamics in living cells | 1 | 2025 |
| R01GM144617 | Regulation and interplay of Heat Shock Factors in growth-associated proteotoxic stresses | 1 | 2025 |
| R01GM151501 | Hsp40 and Hsp70 in Membrane Protein Triage | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10049/grants?page=8